One of the companies which makes new cancer drugs, under review by the HSE for possible approval, is extending its compassionate access programme for people with advanced lung cancer for one month.

Minister for Health Simon Harris yesterday appealed to the manufacturers of two cancer drugs to show “compassion” by continuing to provide the medicines, while they are under review, to patients who need them.